导管切除用于通道病变:什么时候少是多?
Adhya Mehta1, Rishi Chandiramani2, Binita Ghosh3
1Department of Internal Medicine, Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, NY 10461, USA.
Journal of clinical medicine
|April 27, 2024
概括
导管切除提供了一个有前途的替代方案,用于管理心室动 (VF) 在通道病变,可能减少心脏突然死亡和改善生活质量. 需要进一步的研究来确认不同通道病症的长期疗效.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 遗传学 遗传学 是一个
背景情况:
- 心室动 (VF) 是患有通道病症的年轻患者心脏突然死亡的重要原因.
- 目前的治疗方法,如ICD和药物,都有局限性和不良影响.
- 导管切除正在成为一种潜在的治疗选择.
研究的目的:
- 审查导管切除在治疗常见通道病变中的作用和有效性.
- 探索成像和映射方面的进步,以精确识别心律失常触发因素.
- 了解通道病变中心室节律失常的病理生理学.
主要方法:
- 对布鲁加达综合征,先天性长QT综合征,短QT综合征和catecholaminergic多形心室动脉动脉动症的导管切除现有文献的综述.
- 分析成像和绘图技术的进步.
- 讨论潜在的病理生理学,包括Purkinje网络和心上表皮RVOT角色.
主要成果:
- 在布鲁加达综合征中导管切除的初步结果是有希望的.
- 在通道病变中对心律失常的理解得到了改进,突出了特定的解剖区域.
- 废除的长期疗效和耐用性需要对各种通道病变进行进一步的研究.
结论:
- 导管切除是一种潜在的治疗策略,用于心室心律失常在通道病变.
- 进一步的研究是必要的,以确定长期的结果,并将疗效与现有治疗方法进行比较.
- 由于通道病变的遗传和表型多样性,可能需要个性化的方法.
相关概念视频
01:28Disturbances in Heart Rhythm
945
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
945
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
832
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
832
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
980
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
980
01:28Mechanism of Cardiac Arrhythmias
917
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
917
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
741
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
741